These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 11357236)

  • 1. Botulinum toxin treatment in cerebral palsy: evidence for a new treatment option.
    Kirschner J; Berweck S; Mall V; Korinthenberg R; Heinen F
    J Neurol; 2001 Apr; 248 Suppl 1():28-30. PubMed ID: 11357236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type A in the management of equinus in children with cerebral palsy: an evidence-based economic evaluation.
    Houltram J; Noble I; Boyd RN; Corry I; Flett P; Graham HK
    Eur J Neurol; 2001 Nov; 8 Suppl 5():194-202. PubMed ID: 11851748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Efficacy and Side Effects of Oral Baclofen Versus Tizanidine Therapy with Adjuvant Botulinum Toxin Type A in Children With Cerebral Palsy and Spastic Equinus Foot Deformity.
    Dai AI; Aksoy SN; Demiryürek AT
    J Child Neurol; 2016 Feb; 31(2):184-9. PubMed ID: 25999301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type A and dynamic equinus in children with cerebral palsy: new indication. Better than repeat casts.
    Prescrire Int; 2001 Feb; 10(51):12-4. PubMed ID: 11503850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin and short-term electrical stimulation in the treatment of equinus in cerebral palsy.
    Detrembleur C; Lejeune TM; Renders A; Van Den Bergh PY
    Mov Disord; 2002 Jan; 17(1):162-9. PubMed ID: 11835456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of botulinum toxin A (Botox) injections used to treat limb spasticity on speech patterns in children with dysarthria and cerebral palsy: A report of two cases.
    Workinger MS; Kent RD; Meilahn JR
    J Pediatr Rehabil Med; 2017 May; 10(2):137-143. PubMed ID: 28582880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medium-term functional benefits in children with cerebral palsy treated with botulinum toxin type A: 1-year follow-up using gross motor function measure.
    Linder M; Schindler G; Michaelis U; Stein S; Kirschner J; Mall V; Berweck S; Korinthenberg R; Heinen F
    Eur J Neurol; 2001 Nov; 8 Suppl 5():120-6. PubMed ID: 11851740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Botulinum toxin: a new dimension for spasticity].
    Reichel G
    MMW Fortschr Med; 2007 May; 149 Suppl 2():65-9. PubMed ID: 17724971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating spastic equinus foot from cerebral palsy with botulinum toxin type A: what factors influence the results?: an analysis of 189 consecutive cases.
    Pascual-Pascual SI; Pascual-Castroviejo I; Ruiz PJ
    Am J Phys Med Rehabil; 2011 Jul; 90(7):554-63. PubMed ID: 21765274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Letibotulinum Toxin A for the Treatment of Dynamic Equinus Foot Deformity in Children with Cerebral Palsy: A Randomized Controlled Trial.
    Chang HJ; Hong BY; Lee SJ; Lee S; Park JH; Kwon JY
    Toxins (Basel); 2017 Aug; 9(8):. PubMed ID: 28820439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. BOTOX Study Group.
    Koman LA; Mooney JF; Smith BP; Walker F; Leon JM
    J Pediatr Orthop; 2000; 20(1):108-15. PubMed ID: 10641699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type A for the treatment of the spastic equinus foot in cerebral palsy.
    Cardoso ES; Rodrigues BM; Barroso M; Menezes CJ; Lucena RS; Nora DB; Melo A
    Pediatr Neurol; 2006 Feb; 34(2):106-9. PubMed ID: 16458821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.
    Bjornson K; Hays R; Graubert C; Price R; Won F; McLaughlin JF; Cohen M
    Pediatrics; 2007 Jul; 120(1):49-58. PubMed ID: 17606561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of spasticity in children with cerebral palsy with botulinum toxin A].
    Madsen ES; Sonne-Holm S; Wong C; Curtis D; Bencke J
    Ugeskr Laeger; 2015 Jan; 177(3):V07140409. PubMed ID: 25613095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based approach of the use of Botulinum toxin type A (BTX) in cerebral palsy.
    Wong V
    Pediatr Rehabil; 2003; 6(2):85-96. PubMed ID: 14534045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study].
    Mousny M; Allington N
    Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial.
    Koman LA; Brashear A; Rosenfeld S; Chambers H; Russman B; Rang M; Root L; Ferrari E; Garcia de Yebenes Prous J; Smith BP; Turkel C; Walcott JM; Molloy PT
    Pediatrics; 2001 Nov; 108(5):1062-71. PubMed ID: 11694682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What are the long-term consequences of botulinum toxin injections in spastic cerebral palsy?
    Barrett RS
    Dev Med Child Neurol; 2011 Jun; 53(6):485. PubMed ID: 21518344
    [No Abstract]   [Full Text] [Related]  

  • 19. Spread of botulinum neurotoxin type a at standard doses is inherent to the successful treatment of spastic equinus foot in cerebral palsy: short-term neurophysiological and clinical study.
    Frasson E; Dall'ora E; Bordignon M; Brigo F; Tocco P; Primon D; Didonè G; Vicentini S; Fiaschi A; Bertolasi L
    J Child Neurol; 2012 May; 27(5):587-93. PubMed ID: 22114218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy.
    Kay RM; Rethlefsen SA; Fern-Buneo A; Wren TA; Skaggs DL
    J Bone Joint Surg Am; 2004 Nov; 86(11):2377-84. PubMed ID: 15523006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.